Mary E. Cavanaugh, ANP

Mary Cavanaugh practices at The University of Texas MD Anderson Cancer Center in Houston, Texas, part of The University of Texas System.

Mary Cavanaugh's NPI, 1285985341, was assigned on September 28, 2012. Mary Cavanaugh holds Texas license 710251.

Mary Cavanaugh's primary practice is The University of Texas MD Anderson Cancer Center, at 1515 Holcombe Blvd, Houston, TX 77030.

Mary Cavanaugh's primary practice is The University of Texas MD Anderson Cancer Center in Houston, Texas, part of The University of Texas System. The medical group on file is Physicians Referral Service.

Dmand AI tracks the electronic health record (EHR) system at each site where Mary Cavanaugh practices. Vendor and product names are available with a free account.

Nurse practitioner is Mary Cavanaugh's primary specialty in the NPI Registry, under taxonomy code 363L00000X. Mary Cavanaugh is licensed in Texas.

CMS counts 144 Medicare patients who saw Mary Cavanaugh in 2024. The largest group is 65 to 74, with 73 patients. 75% of them have cancer, and 75% have high blood pressure. Their average risk score is 2.56, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Mary Cavanaugh's median patient age at 75, with 3% women.

In 2024, Mary Cavanaugh wrote 995 Medicare Part D claims for 163 patients. 83% of them were for generic drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 84 out of 100 for Mary Cavanaugh for performance year 2024, reported as part of a group. Mary Cavanaugh accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Mary Cavanaugh as offering telehealth.

CMS Open Payments shows 13 general payments to Mary Cavanaugh from 2 drug and device companies in 2025. Food and beverage make up the largest share, 100% of the total. Exelixis Inc. paid the most, $153.